Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ianthus Capital Holdings Inc C.IAN

Alternate Symbol(s):  ITHUF

Healthcare Cannabis Cannabis
iAnthus Capital Holdings, Inc. is a vertically integrated, multi-state owner and operator of licensed cannabis cultivation, processing, and dispensary facilities. The Company is also a developer, producer, and distributor of branded cannabis and cannabidiol (CBD) products in the United States. Through its subsidiaries, the Company owns and/or operates 37 dispensaries and eight cultivation and/or processing facilities in seven United States. Its multi-state operations encompass a full range of medical and adult-use cannabis enterprises, including cultivation, processing, product development, wholesale-distribution, and retail. The Company offers various cannabis products, which includes flower and trim, products containing cannabis flower and trim, such as packaged flower and pre-rolls; cannabis infused products, such as topical creams and edibles and products containing cannabis extracts, such as vape cartridges, concentrates, live resins, wax products, oils, and tinctures.


CSE:IAN - Post by User

Ianthus Capital Holdings Inc > MPX once converted
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1)
•••
Comment by Mike411Ontarioon Jan 10, 2019 10:28am
112 Views
Post# 29211873

RE:RE:MPX once converted

RE:RE:MPX once converted
I copied this from a news letter and it makes sense;
 
By our estimation, the market is valuing MedMen at US$2.4 billion.

         It’s valuing Curaleaf similarly at US$2.9 billion

        iAnthus and MPX combined are trading at nearly a third of these levels.
            
This means that, as investors recognize how much
iAnthus is like the other big cannabis retailers, the stock
price will move a long way to reflect those similarities.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities